News
Urologix to Host Its Fiscal 2008 Third Quarter Conference Call
MINNEAPOLIS-(Business Wire)-April 18, 2008 - Urologix(R), Inc. (Nasdaq: ULGX) will host a conference call to present fiscal 2008 third quarter results on Thursday, April 24, 2008 at 3:30 p.m. CT, following the Company's post-market press release on April 24th. The conference call will be broadcast live over the Internet at www.urologix.com. Mitchell Dann, chairman and interim chief executive officer, will host the call.
Webcast listeners should log on at least 10 minutes prior to the scheduled start time of the call to register and download or install any required audio software. A replay of the call will be available on the Urologix website.
The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.companyboardroom.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the call via CCBN's password-protected event management site, StreetEvents (www.streetevents.com).
About Urologix
Urologix, Inc., based in Minneapolis, develops, manufactures and markets minimally invasive medical products for the treatment of urological disorders. The Company has developed and offers non-surgical, anesthesia-free, catheter-based treatments that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia (BPH), a condition that affects more than 23 million men worldwide. Urologix markets its products under the Targis(R) and Prostatron(R) names. Both systems utilize Cooled ThermoTherapy(TM)— targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort — and provide safe, effective, lasting relief of the symptoms of BPH.
Search Our News Using Google Search
Can't find what you want? Try using Google:
